Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ranok Therapeutics Undisclosed CHAMP-related small molecule
- Development stage
- Unknown
- Lead developer
- Ranok Therapeutics
- Modality
- PROTACs (E3 ligase recruitment) → Targeted Protein Degraders (TPDs) → Small Molecules, Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules
- Administration
- Intravenous
01
Overview
Ranok Therapeutics' undisclosed CHAMP-related small molecule is a discovery-stage therapeutic candidate being developed for the treatment of solid tumors. The program utilizes the company's proprietary Chaperone-Mediated Protein Degrader (CHAMP) technology, which is designed to induce the selective degradation of target proteins by leveraging cellular chaperones and the ubiquitin-proteasome system. This approach aims to overcome limitations of traditional small-molecule inhibitors and other targeted protein degradation (TPD) methods, such as PROTACs, by potentially improving tumor-selective accumulation and reducing systemic toxicity. As of early 2024, the specific biological target for this exploratory program remains undisclosed.
- Other names
- Undisclosed (CHAMP-related exploratory platform)
02
Targets
BRD4 (Bromodomain-containing protein 4)
Beyond the preview
Go deeper on Ranok Therapeutics Undisclosed CHAMP-related small molecule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ranok Therapeutics Undisclosed CHAMP-related small molecule.